Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Dec;50(6):831–835. doi: 10.1038/bjc.1984.263

Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.

S Merry, S B Kaye, R I Freshney
PMCID: PMC1976996  PMID: 6498081

Full text

PDF
831

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baskin F., Rosenberg R. N., Dev V. Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3654–3658. doi: 10.1073/pnas.78.6.3654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beck W. T. Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts. Cancer Treat Rep. 1983 Oct;67(10):875–882. [PubMed] [Google Scholar]
  3. Biedler J. L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 1970 Apr;30(4):1174–1184. [PubMed] [Google Scholar]
  4. Chitnis M. P., Joshi S. S., Gude R. P., Menon R. S. Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin. Chemotherapy. 1982;28(3):209–212. doi: 10.1159/000238078. [DOI] [PubMed] [Google Scholar]
  5. Creaven P. J. The clinical pharmacology of VM26 and VP16-213. A brief overview. Cancer Chemother Pharmacol. 1982;7(2-3):133–140. doi: 10.1007/BF00254535. [DOI] [PubMed] [Google Scholar]
  6. Freshney R. I., Paul J., Kane I. M. Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer. 1975 Jan;31(1):89–99. doi: 10.1038/bjc.1975.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gupta R. S. Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213. Cancer Res. 1983 Apr;43(4):1568–1574. [PubMed] [Google Scholar]
  8. Johnson R. K., Chitnis M. P., Embrey W. M., Gregory E. B. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep. 1978 Oct;62(10):1535–1547. [PubMed] [Google Scholar]
  9. Kartner N., Shales M., Riordan J. R., Ling V. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res. 1983 Sep;43(9):4413–4419. [PubMed] [Google Scholar]
  10. Kaye S. B., Boden J. A. Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivo. Biochem Pharmacol. 1980 Apr 1;29(7):1081–1084. doi: 10.1016/0006-2952(80)90176-8. [DOI] [PubMed] [Google Scholar]
  11. Kessel D., Botterill V., Wodinsky I. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res. 1968 May;28(5):938–941. [PubMed] [Google Scholar]
  12. Morgan D., Freshney R. I., Darling J. L., Thomas D. G., Celik F. Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma. Br J Cancer. 1983 Feb;47(2):205–214. doi: 10.1038/bjc.1983.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nishimura T., Muto K., Tanaka N. Drug sensitivity of an adriamycin-resistant mutant subline of mouse lymphoblastoma L5178Y cells. J Antibiot (Tokyo) 1978 May;31(5):493–495. doi: 10.7164/antibiotics.31.493. [DOI] [PubMed] [Google Scholar]
  14. Seeber S., Osieka R., Schmidt C. G., Achterrath W., Crooke S. T. In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II). Cancer Res. 1982 Nov;42(11):4719–4725. [PubMed] [Google Scholar]
  15. Sethi V. S., Jackson D. V., Jr, White D. R., Richards F., 2nd, Stuart J. J., Muss H. B., Cooper M. R., Spurr C. L. Pharmacokinetics of vincristine sulfate in adult cancer patients. Cancer Res. 1981 Sep;41(9 Pt 1):3551–3555. [PubMed] [Google Scholar]
  16. Shoemaker R. H., Curt G. A., Carney D. N. Evidence for multidrug-resistant cells in human tumor cell populations. Cancer Treat Rep. 1983 Oct;67(10):883–888. [PubMed] [Google Scholar]
  17. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982 Nov;42(11):4730–4733. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES